Small Specialty Pharma Merus Reviews Strategy Amid Sector Woes

Canada’s Merus Labs has recruited Rothschild & Co to review its business strategy, as much larger companies in the specialty market sector retrench with asset sales and job cuts.

More from Strategy

More from Business